Best of ACTHIV® 2023: Initial ART Regimens for the Newly Diagnosed Patient with HIV

Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this module reviews first-line HIV regimens for newly-diagnosed patients with HIV including side effects, discusses rapid ART initiation in newly-diagnosed patients, explores adherence challenges on oral ART and use of long-acting ART, and provides guidance on initial ART if seroconversion occurs on long-acting PrEP.

Review first-line HIV regimens for newly-diagnosed patients with HIV including side effects.
Discuss rapid ART initiation in newly-diagnosed patients
Explore adherence challenges on oral ART and use of long-acting ART.
Apply guidance on initial ART if seroconversion occurs on long-acting PrEP.